LinkedIn Profile

Access Exonate historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:exonate 6908643 Nov 18th, 2019 12:00AM EXONATE LIMITED 197 17.00 Open Pharmaceuticals Nov 18th, 2019 04:14PM Nov 18th, 2019 04:14PM Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration. Open Open Unit 23, Cambridge Science Park Cambridge GB CB4 0EY Exonate
private:exonate 6908643 Nov 17th, 2019 12:00AM EXONATE LIMITED 197 17.00 Open Pharmaceuticals Nov 17th, 2019 04:40PM Nov 17th, 2019 04:40PM Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration. Open Open Unit 23, Cambridge Science Park Cambridge GB CB4 0EY Exonate
private:exonate 6908643 Nov 16th, 2019 12:00AM EXONATE LIMITED 197 17.00 Open Pharmaceuticals Nov 16th, 2019 04:34PM Nov 16th, 2019 04:34PM Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration. Open Open Unit 23, Cambridge Science Park Cambridge GB CB4 0EY Exonate
private:exonate 6908643 Nov 15th, 2019 12:00AM EXONATE LIMITED 197 17.00 Open Pharmaceuticals Nov 15th, 2019 01:14PM Nov 15th, 2019 01:14PM Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration. Open Open Unit 23, Cambridge Science Park Cambridge GB CB4 0EY Exonate
private:exonate 6908643 Nov 13th, 2019 12:00AM EXONATE LIMITED 197 17.00 Open Pharmaceuticals Nov 13th, 2019 01:35PM Nov 13th, 2019 01:35PM Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration. Open Open Unit 23, Cambridge Science Park Cambridge GB CB4 0EY Exonate
private:exonate 6908643 Nov 12th, 2019 12:00AM EXONATE LIMITED 196 17.00 Open Pharmaceuticals Nov 12th, 2019 03:17PM Nov 12th, 2019 03:17PM Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration. Open Open Unit 23, Cambridge Science Park Cambridge GB CB4 0EY Exonate
private:exonate 6908643 Nov 11th, 2019 12:00AM EXONATE LIMITED 196 17.00 Open Pharmaceuticals Nov 11th, 2019 03:15PM Nov 11th, 2019 03:15PM Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration. Open Open Unit 23, Cambridge Science Park Cambridge GB CB4 0EY Exonate
private:exonate 6908643 Nov 10th, 2019 12:00AM EXONATE LIMITED 196 17.00 Open Pharmaceuticals Nov 10th, 2019 06:22PM Nov 10th, 2019 06:22PM Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration. Open Open Unit 23, Cambridge Science Park Cambridge GB CB4 0EY Exonate
private:exonate 6908643 Nov 9th, 2019 12:00AM EXONATE LIMITED 196 17.00 Open Pharmaceuticals Nov 9th, 2019 05:49PM Nov 9th, 2019 05:49PM Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration. Open Open Unit 23, Cambridge Science Park Cambridge GB CB4 0EY Exonate
private:exonate 6908643 Nov 8th, 2019 12:00AM EXONATE LIMITED 196 17.00 Open Pharmaceuticals Nov 8th, 2019 03:00PM Nov 8th, 2019 03:00PM Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration. Open Open Unit 23, Cambridge Science Park Cambridge GB CB4 0EY Exonate

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.